ProCE Banner Activity

Managing the Toxicities of TROP2 Antibody–Drug Conjugates in Lung Cancer

PDF

Download this expert-authored infographic with best practices for identifying and managing key toxicities associated with TROP2 ADCs in lung cancer care.

Released: April 24, 2023

Share

Faculty

Rebecca S. Heist

Rebecca S. Heist, MD MPH

Associate Professor of Medicine
Harvard Medical School
Massachusetts General Hospital Cancer Center
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

AstraZeneca

Daiichi Sankyo, Inc.

Gilead Sciences, Inc.